Apogee Therapeutics, Inc. (APGE) financial statements and ratios from SEC XBRL: revenue $30.03M (TTM), net margin -852.0%, revenue growth -13.6% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $30.03M |
| Net Margin | -852.0% |
| Revenue Growth (YoY) | -13.6% |
| EPS Growth (YoY) | 27.9% |
| FCF Growth (YoY) | 35.0% |
| Price / Sales | 285.18 |
| FCF Yield | -1.7% |
| Altman Z-Score | 165.46 (safe) |
| Sector P/E (Healthcare) | 21.6 |
APGE overview · APGE earnings · APGE KPIs · APGE investor relations · APGE ownership · APGE peers · APGE filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.